Immuneering
Price & Volume
Stats
See more52W Range | $1.10-$10.08 |
Market Cap | $434.5M |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $455 |
Revenue Growth (YoY) | -99.8% |
Gross Profit (12 Mos) | $158,830 |
Diluted EPS | -$1.79 |
News
See moreYahoo Finance • 5 days ago
Immuneering Prepares To Share 12-Month Survival Data In Pancreatic Cancer Trial
Yahoo Finance • 11 days ago
Immuneering To Initiate Phase 3 Atebimetinib Trial In Pancreatic Cancer In Mid-2026
Yahoo Finance • 12 days ago
Immuneering to be Added to the Nasdaq Biotechnology Index (NBI)
Yahoo Finance • last month
Targeted Cancer Therapies Gain Momentum as Precision Market Surges Past $106B
About
CEO | Dr. Benjamin J. Zeskind M.B.A., Ph.D. |
Address | 245 Main Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 54 |
